Business · 30 Oct
Regulators order Sun Pharma to halt eye drug production at Assam plant over quality lapses
AI summaryIndian drug regulators ordered Sun Pharmaceutical to halt manufacturing, selling, and distributing ophthalmic products at its Assam facility due to quality management system failures. This action follows a voluntary recall of about 11 eye-care brands and is part of increased scrutiny of India's drug quality standards.
1 outlet · 1 loaded term flagged